THE SUMMIT TEAM

Michael joined Summit Partners in 2005 as an Associate. Today, as a Managing Director, he focuses primarily on the technology and healthcare & life sciences sectors.

Michael’s current board and investment experience includes Acacia Communications (NASDAQ: ACIA), ApoCell, Clarabridge, Logi Analytics, MacStadium, NetBrain Technologies, Vestmark and Zenoss. His prior experience includes Accedian Networks (acquired by Bridge Growth Partners), Anesthetix (acquired by TeamHealth), Diagnostic Hybrids (acquired by Quidel Corporation), Fermentas International (acquired by Thermo Fisher Scientific), Hiperos (acquired by Opus Global), Mi9 Retail (acquired by General Atlantic), and Telerik (acquired by Progress Software).

Prior to Summit, Michael worked for Prudential Capital Group.

Michael received a BS in finance and international business from Georgetown University.